Chng S, Tern M, Lee Y, Cheng L, Kapur J, Eriksson J
NPJ Digit Med. 2025; 8(1):152.
PMID: 40065130
PMC: 11893894.
DOI: 10.1038/s41746-025-01541-1.
Arabatzis T, Desai B, Baril S, Rasul S, Tekle-Yohannes G, Miller M
BMC Pediatr. 2025; 25(1):151.
PMID: 40016709
PMC: 11869613.
DOI: 10.1186/s12887-024-05093-3.
Caselli D, Arico M, Castagnola E, Gatti M
Antibiotics (Basel). 2025; 14(2).
PMID: 40001365
PMC: 11852066.
DOI: 10.3390/antibiotics14020121.
Massaro A, Fletcher E, Madabushi R, Baer G, Green D
J Pediatr Pharmacol Ther. 2025; 30(1):8-16.
PMID: 39935560
PMC: 11809530.
DOI: 10.5863/1551-6776-30.1.8.
Balis F, Rieger E, Bunin N, Gardiner J, Shaw L, Olson T
Cancer Chemother Pharmacol. 2025; 95(1):32.
PMID: 39932505
PMC: 11813957.
DOI: 10.1007/s00280-025-04757-w.
Infantile undifferentiated sarcomas: a diagnostic and therapeutic challenge - two case reports and literature review.
Stanio A, Czarny J, Rutkowska S, Adamczewska-Wawrzynowicz K, Mlynarczyk L, Strozyk A
Acta Oncol. 2025; 64:241-246.
PMID: 39930783
PMC: 11833329.
DOI: 10.2340/1651-226X.2025.42162.
Data mining and safety analysis of voriconazole in patients with a hematological malignant tumor based on the FAERS database: differences between children and adults.
Li H, Jiang M, Pan X, Kong L
Front Pharmacol. 2025; 16:1524702.
PMID: 39925849
PMC: 11802493.
DOI: 10.3389/fphar.2025.1524702.
Model-informed dose optimization for prophylactic piperacillin-tazobactam in perioperative pediatric critically ill patients.
Tan W, Irie K, McIntire C, Torres J, Jones R, Gibson A
Antimicrob Agents Chemother. 2025; 69(3):e0122724.
PMID: 39912647
PMC: 11881557.
DOI: 10.1128/aac.01227-24.
Safety of dupilumab in Chinese pediatric patients aged 6 months and older: a prospective real-world study.
Chen Y, Ni J, Li M, Hong Y, Zhu K, Hong R
Front Pediatr. 2025; 12:1524962.
PMID: 39895989
PMC: 11782127.
DOI: 10.3389/fped.2024.1524962.
Effectiveness and safety of biosimilars in pediatric inflammatory bowel diseases: an observational longitudinal study on the French National Health Data System.
Jourdain H, Hoisnard L, Sbidian E, Zureik M
World J Pediatr. 2025; 21(1):62-72.
PMID: 39849273
DOI: 10.1007/s12519-024-00873-4.
A Review of Vancomycin, Gentamicin, and Amikacin Population Pharmacokinetic Models in Neonates and Infants.
Albanell-Fernandez M, Rodriguez-Reyes M, Bastida C, Soy D
Clin Pharmacokinet. 2025; 64(1):1-25.
PMID: 39821208
PMC: 11762427.
DOI: 10.1007/s40262-024-01459-z.
Continuous increase in podocyte numbers in the first 36 months of life-insights from forensic autopsies in Japanese children.
Takashima K, Hitosugi M, Uno A, Taniura N, Mukaisho K, Maruo Y
Pediatr Nephrol. 2025; .
PMID: 39792255
DOI: 10.1007/s00467-024-06644-7.
The Development of an Age-Appropriate Fixed Dose Combination for Tuberculosis Using Physiologically-Based Pharmacokinetic Modeling (PBBM) and Risk Assessment.
Pepin X, Johansson Soares Medeiros J, Deris Prado L, Suarez Sharp S
Pharmaceutics. 2025; 16(12.
PMID: 39771565
PMC: 11680012.
DOI: 10.3390/pharmaceutics16121587.
Monitoring of the trough concentration of valproic acid in pediatric epilepsy patients: a machine learning-based ensemble model.
Chen Y, Lin X, Chen S, Zhang Y, Wu W, Huang C
Front Pharmacol. 2025; 15:1521932.
PMID: 39744128
PMC: 11688318.
DOI: 10.3389/fphar.2024.1521932.
Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias.
Palmen R, Walton M, Wagner J
Front Pharmacol. 2025; 15:1477485.
PMID: 39741635
PMC: 11686437.
DOI: 10.3389/fphar.2024.1477485.
Here's the Rub: Skin Care Products and Children's Phthalate Exposures.
Key L
Environ Health Perspect. 2024; 132(12):124002.
PMID: 39666390
PMC: 11636779.
DOI: 10.1289/EHP16068.
Prescription drug use in Danish children and adolescents 2005-2023.
Kildegaard H, Olesen M, Henriksen T, Rasmussen L
Eur J Epidemiol. 2024; 40(1):95-106.
PMID: 39661100
DOI: 10.1007/s10654-024-01186-6.
All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology.
van Valkengoed D, Krekels E, Knibbe C
Clin Pharmacokinet. 2024; 64(2):173-192.
PMID: 39644458
PMC: 11782306.
DOI: 10.1007/s40262-024-01444-6.
Comparison of busulfan pharmacokinetics between four-times-daily and once-daily administration in pediatric patients: a preliminary prospective observational trial.
Yamaguchi A, Hirabayashi S, Niki K, Kagami K, Terashita Y, Cho Y
Int J Hematol. 2024; 121(2):244-251.
PMID: 39625679
DOI: 10.1007/s12185-024-03891-0.
Advancing understanding of human variability through toxicokinetic modeling, in vitro-in vivo extrapolation, and new approach methodologies.
Kreutz A, Chang X, Hogberg H, Wetmore B
Hum Genomics. 2024; 18(1):129.
PMID: 39574200
PMC: 11580331.
DOI: 10.1186/s40246-024-00691-9.
